|
CDKN3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.655200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.625000E-01 |
| Normal-vs-Stage2 |
8.452500E-02 |
| Normal-vs-Stage3 |
3.354600E-01 |
| Normal-vs-Stage4 |
5.309400E-01 |
| Stage1-vs-Stage2 |
3.524600E-03 |
| Stage1-vs-Stage3 |
4.853800E-01 |
| Stage1-vs-Stage4 |
8.392800E-01 |
| Stage2-vs-Stage3 |
4.249600E-02 |
| Stage2-vs-Stage4 |
1.418200E-02 |
| Stage3-vs-Stage4 |
4.792600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.725200E-01 |
| Normal-vs-AfricanAmerican |
1.096840E-01 |
| Normal-vs-Asian |
3.947000E-01 |
| Caucasian-vs-AfricanAmerican |
4.538100E-02 |
| Caucasian-vs-Asian |
6.764600E-01 |
| AfricanAmerican-vs-Asian |
1.558170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.835800E-01 |
| Normal-vs-Female |
3.649600E-01 |
| Male-vs-Female |
9.515600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.612200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.159950E-01 |
| Normal-vs-Age(61-80Yrs) |
3.692000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.399600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.185300E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.852800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.479780E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.012230E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.220100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.814300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.732000E-01 |
| Classical-VS-Follicular |
2.557500E-03 |
| Classical-VS-Other |
5.406000E-01 |
| Classical-VS-Normal |
4.936000E-01 |
| Tall-VS-Follicular |
4.338200E-02 |
| Tall-VS-Other |
3.716800E-01 |
| Tall-VS-Normal |
5.228600E-01 |
| Follicular-VS-Other |
7.964200E-01 |
| Follicular-VS-Normal |
1.067820E-01 |
| Other-VS-Normal |
2.530200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.106000E-01 |
| Normal-vs-N1 |
2.569600E-01 |
| N0-vs-N1 |
7.254000E-01 |
|
|
